Wyndham Hotels & Resorts, Inc. (WH) stock
WHNYSEHotels & MotelsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 22, 2026Score 8/3045% above fair value
$75.20−1.73 (-2.25%)
Close on Oct 30, 2026Market cap $5.58BP/E 27.5Yield 2.18%
Earnings
Wyndham Hotels & Resorts's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 17, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$410.00M
+7.3% on a year earlier
Adjusted diluted EPS, Q3 FY2026
$1.43
$1.46 a year earlier
Latest guidance
Issued
Oct 21, 2026 · 8 items
Quarterly results
Revenue and earnings per share from each of Wyndham Hotels & Resorts's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 17, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 21, 2026after the close | $410.00M | +7.3% | $1.33 | $1.43 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 22, 2026after the close | $375.00M | -5.5% | $1.36 | $1.48 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 29, 2026after the close | $327.00M | +3.5% | $0.80 | $0.96 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 18, 2026after the close | $334.00M | -2.1% | -$0.80 | $0.93 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 22, 2025after the close | $382.00M | -3.5% | $1.36 | $1.46 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 23, 2025after the close | $397.00M | +8.2% | $1.13 | $1.33 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 30, 2025after the close | $316.00M | +3.6% | $0.78 | $0.86 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 12, 2025after the close | $341.00M | +6.2% | $1.08 | $1.04 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 23, 2024after the close | $396.00M | -1.5% | $1.29 | $1.39 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 24, 2024after the close | $367.00M | +2.5% | $1.07 | $1.13 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 24, 2024after the close | $305.00M | -1.0% | $0.19 | $0.78 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 14, 2024after the close | $321.00M | -3.9% | $0.60 | $0.91 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 25, 2023after the close | $402.00M | -1.2% | $1.21 | $1.31 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 26, 2023after the close | $358.00M | -7.3% | $0.82 | $0.93 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 26, 2023after the close | $308.00M | -17.0% | $0.77 | $0.86 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 15, 2023after the close | $334.00M | -14.8% | $0.63 | $0.72 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 25, 2022after the close | $407.00M | -12.1% | $1.13 | $1.21 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 26, 2022after the close | $386.00M | – | $1.00 | $1.07 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 26, 2022after the close | $371.00M | – | $1.14 | $0.95 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 15, 2022after the close | $392.00M | – | $0.52 | $0.69 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 27, 2021after the close | $463.00M | – | $1.09 | $1.16 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 28, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 28, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 10, 2021after the close | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 28, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Wyndham Hotels & Resorts's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net revenuesGAAP | FY2026 | $1.48B – $1.50B | – | New | Oct 21, 2026 |
| Net revenues | FY2026 | $1.48B – $1.50B | $1.47B – $1.50B | Raised | Jul 22, 2026 |
| Year-over-year global RevPAR growthnon-GAAP | FY2026 | +0.5% – +1% | – | New | Oct 21, 2026 |
| Year-over-year global RevPAR growth | FY2026 | -1.5% – +0.5% | – | New | Feb 18, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $740.00M – $745.00M | – | New | Oct 21, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $735.00M – $745.00M | $730.00M – $745.00M | Raised | Jul 22, 2026 |
| Adjusted diluted EPSnon-GAAP | FY2026 | $4.84 – $4.92 | – | New | Oct 21, 2026 |
| Adjusted diluted EPSnon-GAAP | FY2026 | $4.71 – $4.83 | $4.62 – $4.80 | Raised | Jul 22, 2026 |
| Free cash flow conversion ratenon-GAAP | FY2026 | 55% – 60% | – | New | Oct 21, 2026 |
| Free cash flow conversion ratenon-GAAP | FY2026 | 55% – 60% | – | New | Feb 18, 2026 |
| Capital expenditures | FY2026 | $40.00M – $45.00M | – | New | Oct 21, 2026 |
| Capital expenditures | FY2026 | $40.00M – $45.00M | $40.00M – $45.00M | Reaffirmed | Jul 22, 2026 |
| Adjusted income before income taxesnon-GAAP | FY2026 | $473.00M – $487.00M | – | Raised | Jul 22, 2026 |
| Adjusted net incomenon-GAAP | FY2026 | $363.00M – $369.00M | – | New | Oct 21, 2026 |
| Adjusted net incomenon-GAAP | FY2026 | $355.00M – $365.00M | $351.00M – $365.00M | Raised | Jul 22, 2026 |
| Depreciation and amortization expense | FY2026 | $36.00M – $38.00M | – | Lowered | Jul 22, 2026 |
| Development advance notes | FY2026 | $110.00M | $110.00M | Lowered | Jul 22, 2026 |
| Development advance notes amortization expense | FY2026 | $35.00M – $37.00M | – | Lowered | Jul 22, 2026 |
| Free cash flow conversion rate | FY2026 | 55% – 60% | 55% – 60% | Reaffirmed | Jul 22, 2026 |
| Income tax expense | FY2026 | $118.00M – $122.00M | – | Lowered | Jul 22, 2026 |
| Interest expense, net | FY2026 | $144.00M – $146.00M | – | Raised | Jul 22, 2026 |
| Stock-based compensation expense | FY2026 | $41.00M – $43.00M | – | Raised | Jul 22, 2026 |
| Year-over-year global RevPAR growth | FY2026 | 0% – +1% | -1% – +1% | Lowered | Jul 22, 2026 |
| Year-over-year rooms growth | FY2026 | +4% | – | New | Oct 21, 2026 |
| Year-over-year rooms growth | FY2026 | +4% – +4.5% | +4% – +4.5% | Raised | Jul 22, 2026 |
Guidance vs results
The last range Wyndham Hotels & Resorts gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Adjusted diluted EPS | $4.48 – $4.62 | $4.58Σ4Q | Within range |
| FY2025 | Revenue | $1.43B – $1.45B | $1.43BΣ4Q | Below range |
Guidance history
Every forecast Wyndham Hotels & Resorts put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 21, 2026 | Capital expenditures | FY2026 | $40.00M – $45.00M | New |
| Oct 21, 2026 | Year-over-year global RevPAR growth | FY2026 | +0.5% – +1% | New |
| Oct 21, 2026 | Adjusted EBITDA | FY2026 | $740.00M – $745.00M | New |
| Oct 21, 2026 | Adjusted diluted EPS | FY2026 | $4.84 – $4.92 | New |
| Oct 21, 2026 | Free cash flow conversion rate | FY2026 | 55% – 60% | New |
| Oct 21, 2026 | Adjusted net income | FY2026 | $363.00M – $369.00M | New |
| Oct 21, 2026 | Year-over-year rooms growth | FY2026 | +4% | New |
| Oct 21, 2026 | Net revenues | FY2026 | $1.48B – $1.50B | New |
| Jul 22, 2026 | Capital expenditures | FY2026 | $40.00M – $45.00M | Reaffirmed |
| Jul 22, 2026 | Adjusted EBITDA | FY2026 | $735.00M – $745.00M | Raised |
| Jul 22, 2026 | Adjusted diluted EPS | FY2026 | $4.71 – $4.83 | Raised |
| Jul 22, 2026 | Stock-based compensation expense | FY2026 | $41.00M – $43.00M | Raised |
| Jul 22, 2026 | Free cash flow conversion rate | FY2026 | 55% – 60% | Reaffirmed |
| Jul 22, 2026 | Year-over-year rooms growth | FY2026 | +4% – +4.5% | Raised |
| Jul 22, 2026 | Year-over-year global RevPAR growth | FY2026 | 0% – +1% | Lowered |
| Jul 22, 2026 | Depreciation and amortization expense | FY2026 | $36.00M – $38.00M | Lowered |
| Jul 22, 2026 | Development advance notes amortization expense | FY2026 | $35.00M – $37.00M | Lowered |
| Jul 22, 2026 | Interest expense, net | FY2026 | $144.00M – $146.00M | Raised |
| Jul 22, 2026 | Income tax expense | FY2026 | $118.00M – $122.00M | Lowered |
| Jul 22, 2026 | Development advance notes | FY2026 | $110.00M | Lowered |
| Jul 22, 2026 | Adjusted net income | FY2026 | $355.00M – $365.00M | Raised |
| Jul 22, 2026 | Adjusted income before income taxes | FY2026 | $473.00M – $487.00M | Raised |
| Jul 22, 2026 | Net revenues | FY2026 | $1.48B – $1.50B | Raised |
| Apr 29, 2026 | Capital expenditures | FY2026 | $40.00M – $45.00M | Reaffirmed |
| Apr 29, 2026 | Adjusted EBITDA | FY2026 | $730.00M – $745.00M | Reaffirmed |
| Apr 29, 2026 | Adjusted diluted EPS | FY2026 | $4.62 – $4.80 | Reaffirmed |
| Apr 29, 2026 | Free cash flow conversion rate | FY2026 | 55% – 60% | New |
| Apr 29, 2026 | Year-over-year rooms growth | FY2026 | +4% – +4.5% | Reaffirmed |
| Apr 29, 2026 | Year-over-year global RevPAR growth | FY2026 | -1% – +1% | Lowered |
| Apr 29, 2026 | Development advance notes | FY2026 | $110.00M | New |
| Apr 29, 2026 | Adjusted net income | FY2026 | $351.00M – $365.00M | Lowered |
| Apr 29, 2026 | Net revenues | FY2026 | $1.47B – $1.50B | Raised |
| Feb 18, 2026 | Capital expenditures | FY2026 | $40.00M – $45.00M | New |
| Feb 18, 2026 | Year-over-year global RevPAR growth | FY2026 | -1.5% – +0.5% | New |
| Feb 18, 2026 | Adjusted EBITDA | FY2026 | $730.00M – $745.00M | New |
| Feb 18, 2026 | Adjusted diluted EPS | FY2026 | $4.62 – $4.80 | New |
| Feb 18, 2026 | Free cash flow conversion rate | FY2026 | 55% – 60% | New |
| Feb 18, 2026 | Year-over-year rooms growth | FY2026 | +4% – +4.5% | New |
| Feb 18, 2026 | Adjusted net income | FY2026 | $354.00M – $368.00M | New |
| Feb 18, 2026 | Fee-related and other revenues | FY2026 | $1.46B – $1.49B | New |
| Oct 22, 2025 | Capital expenditures | FY2025 | $40.00M – $45.00M | New |
| Oct 22, 2025 | Adjusted EBITDA | FY2025 | $715.00M – $725.00M | New |
| Oct 22, 2025 | Adjusted diluted EPS | FY2025 | $4.48 – $4.62 | New |
| Oct 22, 2025 | Adjusted free cash flow conversion rate | FY2025 | 57% | New |
| Oct 22, 2025 | Year-over-year rooms growth | FY2025 | +4% – +4.6% | New |
| Oct 22, 2025 | Year-over-year global RevPAR growth | FY2025 | -3% – -2% | Lowered |
| Oct 22, 2025 | Fee-related and other revenues | FY2025 | $1.43B – $1.45B | New |
| Jul 23, 2025 | Capital expenditures | FY2025 | $40.00M – $45.00M | Reaffirmed |
| Jul 23, 2025 | Year-over-year global RevPAR growth | FY2025 | -2% – +1% | New |
| Jul 23, 2025 | Adjusted EBITDA | FY2025 | $730.00M – $745.00M | Reaffirmed |
| Jul 23, 2025 | Adjusted diluted EPS | FY2025 | $4.60 – $4.78 | Raised |
| Jul 23, 2025 | Diluted shares | FY2025 | 77.8 | New |
| Jul 23, 2025 | Adjusted free cash flow conversion rate | FY2025 | 57% | Reaffirmed |
| Jul 23, 2025 | Year-over-year rooms growth | FY2025 | +4% – +4.6% | Raised |
| Jul 23, 2025 | Depreciation and amortization expense | FY2025 | $37.00M – $39.00M | Lowered |
| Jul 23, 2025 | Development advance notes amortization expense | FY2025 | $32.00M – $34.00M | Lowered |
| Jul 23, 2025 | Stock-based compensation expense | FY2025 | $42.00M – $44.00M | Raised |
| Jul 23, 2025 | Interest expense, net | FY2025 | $136.00M – $138.00M | Raised |
| Jul 23, 2025 | Income tax expense | FY2025 | $119.00M – $125.00M | Lowered |
| Jul 23, 2025 | Development advance notes | FY2025 | $110.00M | Lowered |
| Jul 23, 2025 | Adjusted net income | FY2025 | $358.00M – $372.00M | Raised |
| Jul 23, 2025 | Adjusted income before income taxes | FY2025 | $477.00M – $496.00M | Raised |
| Jul 23, 2025 | Fee-related and other revenues | FY2025 | $1.45B – $1.49B | Lowered |
| Apr 30, 2025 | Capital expenditures | FY2025 | $40.00M – $45.00M | Reaffirmed |
| Apr 30, 2025 | Adjusted EBITDA | FY2025 | $730.00M – $745.00M | Lowered |
| Apr 30, 2025 | Adjusted diluted EPS | FY2025 | $4.57 – $4.74 | Lowered |
| Apr 30, 2025 | Diluted shares | FY2025 | 78.4 | New |
| Apr 30, 2025 | Free cash flow conversion rate | FY2025 | 57% | New |
| Apr 30, 2025 | Year-over-year rooms growth | FY2025 | +3.6% – +4.6% | New |
| Apr 30, 2025 | Year-over-year global RevPAR growth | FY2025 | -2% – +1% | Lowered |
| Apr 30, 2025 | Development advance notes | FY2025 | $110.00M | Reaffirmed |
| Apr 30, 2025 | Adjusted net income | FY2025 | $358.00M – $372.00M | Lowered |
| Apr 30, 2025 | Depreciation and amortization expense | FY2025 | $37.00M – $39.00M | Lowered |
| Apr 30, 2025 | Development advance notes amortization expense | FY2025 | $32.00M – $34.00M | Lowered |
| Apr 30, 2025 | Stock-based compensation expense | FY2025 | $42.00M – $44.00M | Raised |
| Apr 30, 2025 | Interest expense, net | FY2025 | $136.00M – $138.00M | Raised |
| Apr 30, 2025 | Adjusted income before income taxes | FY2025 | $477.00M – $496.00M | Raised |
| Apr 30, 2025 | Income tax expense | FY2025 | $119.00M – $125.00M | Lowered |
| Apr 30, 2025 | Fee-related and other revenues | FY2025 | $1.45B – $1.49B | New |
| Feb 12, 2025 | Capital expenditures | FY2025 | $40.00M – $45.00M | New |
| Feb 12, 2025 | Adjusted EBITDA | FY2025 | $745.00M – $755.00M | New |
| Feb 12, 2025 | Adjusted diluted EPS | FY2025 | $4.66 – $4.78 | New |
| Feb 12, 2025 | Year-over-year global RevPAR growth (a) | FY2025 | +2% – +3% | Lowered |
| Feb 12, 2025 | Depreciation and amortization expense (b) | FY2025 | $39.00M – $41.00M | New |
| Feb 12, 2025 | Development advance notes amortization expense | FY2025 | $32.00M – $34.00M | Lowered |
| Feb 12, 2025 | Stock-based compensation expense | FY2025 | $42.00M – $44.00M | Raised |
| Feb 12, 2025 | Income tax expense (c) | FY2025 | $123.00M – $127.00M | Lowered |
| Feb 12, 2025 | Development advance notes | FY2025 | $110.00M | Lowered |
| Feb 12, 2025 | Adjusted net income | FY2025 | $369.00M – $379.00M | New |
| Feb 12, 2025 | Interest expense, net | FY2025 | $134.00M – $136.00M | Raised |
| Feb 12, 2025 | Free cash flow conversion rate | FY2025 | 57% – 60% | New |
| Feb 12, 2025 | Year-over-year rooms growth | FY2025 | +3.6% – +4.6% | New |
| Feb 12, 2025 | Adjusted income before income taxes | FY2025 | $492.00M – $506.00M | Raised |
| Feb 12, 2025 | Fee-related and other revenues | FY2025 | $1.49B – $1.51B | New |
| Oct 23, 2024 | Capital expenditures | FY2024 | $40.00M | New |
| Oct 23, 2024 | Adjusted EBITDA | FY2024 | $690.00M – $700.00M | Reaffirmed |
| Oct 23, 2024 | Adjusted diluted EPS | FY2024 | $4.22 – $4.34 | Raised |
| Oct 23, 2024 | Diluted shares | FY2024 | 80.1 | New |
| Oct 23, 2024 | Adjusted free cash flow conversion rate | FY2024 | 60% | New |
| Oct 23, 2024 | Year-over-year rooms growth | FY2024 | +3% – +4% | Reaffirmed |
| Oct 23, 2024 | Adjusted net income | FY2024 | $338.00M – $348.00M | Reaffirmed |
| Oct 23, 2024 | Depreciation and amortization expense | FY2024 | $45.00M – $47.00M | Lowered |
| Oct 23, 2024 | Development advance notes amortization expense | FY2024 | $23.00M – $25.00M | Lowered |
| Oct 23, 2024 | Stock-based compensation expense | FY2024 | $41.00M – $43.00M | Raised |
| Oct 23, 2024 | Interest expense, net | FY2024 | $125.00M – $127.00M | Raised |
| Oct 23, 2024 | Adjusted income before income taxes | FY2024 | $450.00M – $464.00M | Raised |
| Oct 23, 2024 | Income tax expense | FY2024 | $113.00M – $116.00M | Lowered |
| Oct 23, 2024 | Development advance notes | FY2024 | $110.00M | Lowered |
| Oct 23, 2024 | Fee-related and other revenues | FY2024 | $1.41B – $1.43B | New |
| Jul 24, 2024 | Capital expenditures | FY2024 | $40.00M | Reaffirmed |
| Jul 24, 2024 | Adjusted EBITDA | FY2024 | $690.00M – $700.00M | Reaffirmed |
| Jul 24, 2024 | Adjusted diluted EPS | FY2024 | $4.20 – $4.32 | Raised |
| Jul 24, 2024 | Adjusted free cash flow conversion rate | FY2024 | 60% | Reaffirmed |
| Jul 24, 2024 | Number of rooms | FY2024 | +3% – +4% | Reaffirmed |
| Jul 24, 2024 | Adjusted net income | FY2024 | $338.00M – $348.00M | Lowered |
| Jul 24, 2024 | Fee-related and other revenues | FY2024 | $1.41B – $1.43B | Lowered |
| Apr 24, 2024 | Capital expenditures | FY2024 | $40.00M | Reaffirmed |
| Apr 24, 2024 | Global RevPAR | FY2024 | +2% – +3% | Reaffirmed |
| Apr 24, 2024 | Adjusted EBITDA | FY2024 | $690.00M – $700.00M | Reaffirmed |
| Apr 24, 2024 | Adjusted diluted EPS | FY2024 | $4.18 – $4.30 | Raised |
| Apr 24, 2024 | Adjusted free cash flow conversion rate | FY2024 | 60% | Reaffirmed |
| Apr 24, 2024 | Stock-based compensation expense | FY2024 | $43.00M – $45.00M | Raised |
| Apr 24, 2024 | Income tax expense | FY2024 | $114.00M – $117.00M | Raised |
| Apr 24, 2024 | Development advance notes | FY2024 | $90.00M | Lowered |
| Apr 24, 2024 | Interest expense, net | FY2024 | $118.00M – $120.00M | Lowered |
| Apr 24, 2024 | Adjusted income before income taxes | FY2024 | $454.00M – $468.00M | Raised |
| Apr 24, 2024 | Adjusted net income | FY2024 | $341.00M – $351.00M | Lowered |
| Apr 24, 2024 | Diluted shares | FY2024 | 81.6 | New |
| Apr 24, 2024 | Number of rooms | FY2024 | +3% – +4% | Reaffirmed |
| Apr 24, 2024 | Depreciation and amortization expense | FY2024 | $46.00M – $48.00M | New |
| Apr 24, 2024 | Development advance notes amortization expense | FY2024 | $23.00M – $25.00M | Lowered |
| Apr 24, 2024 | Fee-related and other revenues | FY2024 | $1.43B – $1.46B | Reaffirmed |
| Feb 14, 2024 | Capital expenditures | FY2024 | $40.00M | New |
| Feb 14, 2024 | Year-over-year global RevPAR growth | FY2024 | +2% – +3% | New |
| Feb 14, 2024 | Adjusted EBITDA | FY2024 | $690.00M – $700.00M | New |
| Feb 14, 2024 | Adjusted diluted EPS | FY2024 | $4.11 – $4.23 | New |
| Feb 14, 2024 | Free cash flow conversion rate | FY2024 | 60% | New |
| Feb 14, 2024 | Year-over-year rooms growth | FY2024 | +3% – +4% | New |
| Feb 14, 2024 | Adjusted net income | FY2024 | $341.00M – $351.00M | New |
| Feb 14, 2024 | Fee-related and other revenues | FY2024 | $1.43B – $1.46B | New |
| Oct 25, 2023 | Capital expenditures | FY2023 | $35.00M | Reaffirmed |
| Oct 25, 2023 | Year-over-year global RevPAR growth | FY2023 | +4% – +6% | Reaffirmed |
| Oct 25, 2023 | Adjusted EBITDA | FY2023 | $654.00M – $664.00M | Reaffirmed |
| Oct 25, 2023 | Adjusted diluted EPS | FY2023 | $3.94 – $4.08 | Raised |
| Oct 25, 2023 | Free cash flow conversion rate | FY2023 | 50% – 55% | New |
| Oct 25, 2023 | Year-over-year rooms growth | FY2023 | +2% – +4% | Reaffirmed |
| Oct 25, 2023 | Adjusted net income | FY2023 | $336.00M – $348.00M | Reaffirmed |
| Oct 25, 2023 | Fee-related and other revenues | FY2023 | $1.38B – $1.41B | Reaffirmed |
| Jul 26, 2023 | Capital expenditures | FY2023 | $35.00M | Reaffirmed |
| Jul 26, 2023 | Year-over-year global RevPAR growth | FY2023 | +4% – +6% | Reaffirmed |
| Jul 26, 2023 | Adjusted EBITDA | FY2023 | $654.00M – $664.00M | Reaffirmed |
| Jul 26, 2023 | Adjusted diluted EPS | FY2023 | $3.92 – $4.06 | Reaffirmed |
| Jul 26, 2023 | Free cash flow conversion rate | FY2023 | 50% – 55% | Reaffirmed |
| Jul 26, 2023 | Year-over-year rooms growth | FY2023 | +2% – +4% | Reaffirmed |
| Jul 26, 2023 | Adjusted net income | FY2023 | $336.00M – $348.00M | Lowered |
| Jul 26, 2023 | Fee-related and other revenues | FY2023 | $1.38B – $1.41B | Reaffirmed |
| Apr 26, 2023 | Capital expenditures | FY2023 | $35.00M | Reaffirmed |
| Apr 26, 2023 | Year-over-year global RevPAR growth | FY2023 | +4% – +6% | Reaffirmed |
| Apr 26, 2023 | Adjusted EBITDA | FY2023 | $654.00M – $664.00M | Raised |
| Apr 26, 2023 | Adjusted diluted EPS | FY2023 | $3.92 – $4.06 | Raised |
| Apr 26, 2023 | Free cash flow conversion rate | FY2023 | 50% – 55% | Reaffirmed |
| Apr 26, 2023 | Year-over-year rooms growth | FY2023 | +2% – +4% | Reaffirmed |
| Apr 26, 2023 | Adjusted net income | FY2023 | $340.00M – $352.00M | Raised |
| Apr 26, 2023 | Fee-related and other revenues | FY2023 | $1.38B – $1.41B | Reaffirmed |
| Feb 15, 2023 | Capital expenditures | FY2023 | $35.00M | New |
| Feb 15, 2023 | Year-over-year global RevPAR growth | FY2023 | +4% – +6% | New |
| Feb 15, 2023 | Adjusted EBITDA | FY2023 | $650.00M – $660.00M | New |
| Feb 15, 2023 | Adjusted diluted EPS | FY2023 | $3.84 – $3.98 | New |
| Feb 15, 2023 | Free cash flow conversion rate | FY2023 | 50% – 55% | New |
| Feb 15, 2023 | Year-over-year rooms growth | FY2023 | +2% – +4% | New |
| Feb 15, 2023 | Adjusted net income | FY2023 | $337.00M – $349.00M | New |
| Feb 15, 2023 | Fee-related and other revenues | FY2023 | $1.38B – $1.41B | New |
| Oct 25, 2022 | Capital expenditures | FY2022 | $40.00M | Reaffirmed |
| Oct 25, 2022 | Year-over-year global RevPAR growth | FY2022 | +14% – +16% | Raised |
| Oct 25, 2022 | Adjusted EBITDA | FY2022 | $636.00M – $644.00M | Raised |
| Oct 25, 2022 | Adjusted diluted EPS | FY2022 | $3.84 – $3.89 | Raised |
| Oct 25, 2022 | Free cash flow conversion rate | FY2022 | 55% | Reaffirmed |
| Oct 25, 2022 | Year-over-year rooms growth | FY2022 | +4% | Raised |
| Oct 25, 2022 | Adjusted net income | FY2022 | $349.00M – $354.00M | Raised |
| Oct 25, 2022 | Fee-related and other revenues | FY2022 | $1.33B – $1.34B | Raised |
| Jul 26, 2022 | Year-over-year global RevPAR growth | FY2022 | +12% – +16% | Reaffirmed |
| Jul 26, 2022 | Adjusted EBITDA | FY2022 | $611.00M – $631.00M | Raised |
| Jul 26, 2022 | Adjusted diluted EPS | FY2022 | $3.51 – $3.63 | Raised |
| Jul 26, 2022 | Free cash flow conversion rate | FY2022 | 55% | New |
| Jul 26, 2022 | Year-over-year rooms growth | FY2022 | +2% – +4% | Reaffirmed |
| Jul 26, 2022 | Adjusted net income | FY2022 | $323.00M – $334.00M | Raised |
| Jul 26, 2022 | Fee-related and other revenues | FY2022 | $1.29B – $1.32B | Raised |
| Apr 26, 2022 | Capital expenditures | FY2022 | $40.00M | New |
| Apr 26, 2022 | Year-over-year global RevPAR growth | FY2022 | +12% – +16% | Reaffirmed |
| Apr 26, 2022 | Adjusted EBITDA | FY2022 | $605.00M – $625.00M | Reaffirmed |
| Apr 26, 2022 | Adjusted diluted EPS | FY2022 | $3.39 – $3.51 | Raised |
| Apr 26, 2022 | Free cash flow conversion rate | FY2022 | 55% | Reaffirmed |
| Apr 26, 2022 | Year-over-year rooms growth | FY2022 | +2% – +4% | Reaffirmed |
| Apr 26, 2022 | Adjusted net income | FY2022 | $317.00M – $329.00M | Raised |
| Apr 26, 2022 | Fee-related and other revenues | FY2022 | $1.28B – $1.31B | Lowered |
| Feb 15, 2022 | RevPAR growth | FY2022 | +12% – +16% | New |
| Feb 15, 2022 | Adjusted EBITDA | FY2022 | $605.00M – $625.00M | New |
| Feb 15, 2022 | Adjusted diluted EPS | FY2022 | $3.28 – $3.40 | New |
| Feb 15, 2022 | Free cash flow conversion from adjusted EBITDA | FY2022 | 55% | New |
| Feb 15, 2022 | Net rooms growth | FY2022 | +2% – +4% | New |
| Feb 15, 2022 | Adjusted net income | FY2022 | $308.00M – $320.00M | New |
| Feb 15, 2022 | Fee-related and other revenues | FY2022 | $1.34B – $1.37B | New |
| Oct 27, 2021 | RevPAR growth | FY2021 | +43% | New |
| Oct 27, 2021 | Adjusted EBITDA | FY2021 | $560.00M – $570.00M | New |
| Oct 27, 2021 | Adjusted diluted EPS | FY2021 | $2.93 – $3.03 | New |
| Oct 27, 2021 | Free cash conversion from Adjusted EBITDA | FY2021 | 60% | New |
| Oct 27, 2021 | Net rooms growth | FY2021 | +1.5% – +2% | New |
| Oct 27, 2021 | Adjusted net income | FY2021 | $275.00M – $285.00M | New |
| Oct 27, 2021 | Fee-related and other revenues | FY2021 | $1.21B – $1.23B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Wyndham Hotels & Resorts filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- News
- Results
- Update
- News
- News
- Results
- News
- Update
- Results
- Results
- Results
- Results
- Results